Last edition
News about "COPD treatment"
Boehringer Ingelheim Starts Phase 3 COPD Trial of Verducatib
Boehringer Ingelheim has launched phase 3 AIRWARD trial to assess verducatib’s safety and efficacy in adults with symptomatic COPD.
COPD Treatment | 02/11/2026 | By News Bureau | 137
Sino Biopharma and AstraZeneca Sign Licensing Deal for TQC3721
Sino Biopharmaceutical has signed an exclusive licensing agreement with AstraZeneca to develop, manufacture, and commercialise TQC3721, a novel PDE3/4 inhibitor for respiratory diseases.
COPD Treatment | 09/07/2026 | By News Bureau | 170
Altesa BioSciences Initiates Phase IIb CARDINAL Trial for COPD Treatment
Altesa BioSciences begins global CARDINAL trial to assess antiviral vapendavir for improving symptoms and lung function in COPD patients.
COPD Treatment | 06/05/2026 | By News Bureau | 261
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy